NCT06037902Recruiting

CPAP for Esophageal Cancer With Radiotherapy

Name: Clinical Trial NCT06037902
Creator: Sheba Medical Center
Keywords: Esophageal Cancer, CPAP, device, clinical trial, Israel

Use of CPAP (Continuous Positive Airway Pressure) for Simulating Esophageal Cancer Patients Prior to Radiotherapy

Sheba Medical CenterClinicalTrials.govdeviceDevice trial

Verified

Study focus

Disease/Condition: Esophageal Cancer
Drug/Device/Intervention: CPAP
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: Sheba Medical Center
Location: Ramat Gan, Israel

Timeline & enrollment

Phase: N/A
Start date: Aug 21, 2023
End date: Sep 30, 2027
Enrollment: 44 participants

Primary outcome

absolute mean heart radiation dose

Summary

The goal of this clinical trial is to test the use of CPAP in patients with esophgaeal cancer undergoing radiotherapy.  The main questions it aims to answer are:  - does use of CPAP decrease exposure of normal lung to radiation?  - does use of CPAP decrease exposure of normal heart to radiation?  Participants will undergo simulation twice:  - with CPAP  - without CPAP

ICD-10 classifications

Carcinoma in situ: OesophagusMalignant neoplasm of oesophagusMalignant neoplasm: Middle third of oesophagusMalignant neoplasm: Overlapping lesion of oesophagusMalignant neoplasm: Upper third of oesophagus

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06037902
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06037902 through Pure Global AI's free database. This phase not specified trial is sponsored by Sheba Medical Center and is currently Recruiting. The study focuses on Esophageal Cancer. Target enrollment is 44 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.